Abstract
AbstractCharcot-Marie-Tooth disease type 2Z is caused by MORC2 mutations and presents with axonal neuropathy. MORC2 mutations can also manifest as developmental delay, impaired growth, dysmorphic facies, and axonal neuropathy (DIGFAN). We report a patient exhibiting an intermediate phenotype between these diseases associated with a novel MORC2 variant. A literature review revealed that the genotype‒phenotype correlation in MORC2-related disorders is complex and that the same mutation can cause a variety of phenotypes.
Publisher
Springer Science and Business Media LLC
Reference16 articles.
1. Murakami, T. & Sunada, Y. Schwann cell and the pathogenesis of Charcot-Marie-Tooth disease. Adv. Exp. Med. Biol. 1190, 301–321 (2019).
2. Hertzog, N. & Jacob, C. Mechanisms and treatment strategies of demyelinating and dysmyelinating Charcot-Marie-Tooth disease. Neural Regen. Res. 18, 1931–1939 (2023).
3. Pipis, M., Rossor, A. M., Laura, M. & Reilly, M. M. Next-generation sequencing in Charcot-Marie-Tooth disease: opportunities and challenges. Nat. Rev. Neurol. 15, 644–656 (2019).
4. Sevilla, T. et al. Mutations in the MORC2 gene cause axonal Charcot-Marie-Tooth disease. Brain 139, 62–72 (2016).
5. Sancho, P. et al. Characterization of molecular mechanisms underlying the axonal Charcot-Marie-Tooth neuropathy caused by MORC2 mutations. Hum. Mol. Genet 28, 1629–1644 (2019).